NWS
66
-3
XRAY
28
2
VTR
47
-7
WBA
48
4
URBN
56
14
HRB
57
5
MAT
46
12
CL
58
2
CSCO
67
4
MSFT
50
3
PG
56
5
COF
60
2
NDAQ
62
2
NSC
60
3
DE
63
3
DHI
48
4
URI
65
5
RL
72
4
NVDA
56
-4
PSA
58
2
NWS
66
-3
XRAY
28
2
VTR
47
-7
WBA
48
4
URBN
56
14
HRB
57
5
MAT
46
12
CL
58
2
CSCO
67
4
MSFT
50
3
PG
56
5
COF
60
2
NDAQ
62
2
NSC
60
3
DE
63
3
DHI
48
4
URI
65
5
RL
72
4
NVDA
56
-4
PSA
58
2
Financhill
Back

Standard BioTools 10K Form

Sell
41

LAB
Standard BioTools

Last Price:
1.60
Seasonality Move:
19.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LAB News And Ratings

See the #1 stock for the next 7 days that we like better than LAB

LAB Financial Statistics

Sales & Book Value

Annual Sales: $106.34M
Cash Flow: $-30.12M
Price / Cash Flow: 0
Annual Sales: $1.31
Price / Book: 1.22

Profitability

EPS (TTM): -0.71000
Net Income (TTM): $-124.59M
Gross Margin: $50.45M
Return on Equity: -48.03%
Return on Assets: -22.01%

Standard BioTools Earnings Forecast

Key Standard BioTools Financial Ratios

  • The Gross Profit Margin over the past 18 years for LAB is 47.44%.
  • The Selling, General & Administrative Expenses for LAB have been equal to 82.32% of Gross Profit Margin.
  • The Research & Development expenses have been 24.40% of Revenue.
  • The Interest Expense is -6.12% of Operating Income.
  • The Net Earning history of LAB is -70.21% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 10 years.

Standard BioTools Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: LAB
Website: standardbio.com

Debt

Debt-to-Equity Ratio: 0.11
Current Ratio: 3.76
Quick Ratio: 3.33

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LAB Technical Analysis vs Fundamental Analysis

Sell
41
Standard BioTools (LAB) is a Sell

Is Standard BioTools a Buy or a Sell?

  • Standard BioTools stock is rated a Sell
    The current Standard BioTools [LAB] share price is $1.60. The Score for LAB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.